IEquol an isoflavonoid: Potential for improved prostate health, in vitro and in vivo evidence

Reproductive Biology and Endocrinology

Volumn 9, Issue , 2011, Pages

  Lund, Trent D ^a   Blake, Crystal ^b   Bu, Lihong ^c   Hamaker, Amy N ^b   Lephart, Edwin D ^b  

^a Stoelting Co   (United States)

^b BRIGHAM YOUNG UNIVERSITY   (United States)

^c BOSTON CHILDREN S HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANDROSTANOLONE; DIMETHYL SULFOXIDE; EQUOL; ESTRADIOL; ISOFLAVONOID; LUTEINIZING HORMONE; PROSTATE SPECIFIC ANTIGEN; SEPHADEX; STEROID HORMONE; TESTOSTERONE; ISOFLAVONE DERIVATIVE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ASSAY; BINDING AFFINITY; BLOOD SAMPLING; CANCER CELL; CELL CULTURE; CELL STRAIN LNCAP; COLUMN CHROMATOGRAPHY; CONTROLLED STUDY; DRUG EFFECT; ENZYME LINKED IMMUNOSORBENT ASSAY; EVIDENCE BASED PRACTICE; HEALTH STATUS; HORMONE BLOOD LEVEL; HUMAN; HUMAN CELL; HUMAN TISSUE; IN VITRO STUDY; IN VIVO STUDY; MALE; NONHUMAN; PROSTATE CANCER; RAT; SCINTILLATION COUNTING; STANDARD; ANIMAL; DRUG ANTAGONISM; METABOLISM; PROSTATE; PROSTATE TUMOR; TUMOR CELL LINE;

ANIMALIA; RATTUS;

ANIMALS; CELL LINE, TUMOR; DIHYDROTESTOSTERONE; HUMANS; ISOFLAVONES; MALE; PROSTATE; PROSTATE-SPECIFIC ANTIGEN; PROSTATIC NEOPLASMS; RATS;

EID: 78651320934     PISSN: None     EISSN: 14777827     Source Type: Journal    
DOI: 10.1186/1477-7827-9-4     Document Type: Article

References (31)

1. Manach C, Williamson G, Morand C, Scalbert A, Rémésy C. Bioavailability and bioefficacy of polyphenols in humans. I. Review of 97 bioavailability studies. Am J Clin Nutr 2005, 81(Suppl):230S-242S.
2. Jamison JR. Clinical Guide To Nutrition and Dietary Supplements in Disease 2003, Amsterdam, Netherland, Churchhill Livingstone/Elsevier.
3. Adlercreutz H. Phyto-oestrogens and cancer. Lancet Oncol 2002, 3:364-373. 10.1016/S1470-2045(02)00777-5, 12107024.
4. Setchell KD, Brown NM, Lydeking-Olsen E. The clinical importance of the metabolite equol - a clue to the effectiveness of soy and its isoflavones. J Nutr 2002, 132:3577-3584.
5. Setchell KD, Clerici C, Lephart ED, Cole SJ, Heenan C, Castellani D, Wolfe BE, Nechemias-Zimmer L, Brown NM, Lund TD, Handa RJ, Heubi JE. S-equol, a potent ligand for estrogen receptor beta, is the exclusive enantiomeric form of the soy isoflavone metabolite produced by human intestinal bacterial flora. Am J Clin Nutr 2005, 81:1072-1079.
6. Hounsome N, Hounsome B, Tomos D, Edward-Jones G. Changes in Antioxidant Compounds in White Cabbage During Winter Storage. Postharvest Biol Tech 2009, 52:173-179.
7. Lund TD, Munson DJ, Haldy ME, Setchell KDR, Lephart ED, Handa RJ. Equol is a novel anti-androgen that inhibits prostate growth and hormone feedback. Biol Reprod 2004, 70:1188-1195. 10.1095/biolreprod.103.023713, 14681200.
8. Yang Q, Fung KM, Day WV, Kropp BP, Lin HK. Androgen receptor signaling is required for androgen-sensitive human prostate cancer cell proliferation and survival. Cancer Cell International 2005, 5:8. 10.1186/1475-2867-5-8, 1087496, 15813967.
9. Lee C, Sutkowski DM, Sensibar JA, Zelner D, Kim I, Amsel I, Shaw N, Prins GS, Kozlowski JM. Regulation of proliferation and production of prostate-specific antigen in androgen-sensitive prostate cancer cells. Endocrinology 1995, 136:796-803. 10.1210/en.136.2.796, 7530653.
10. Ozasa K, Nakao M, Watanabe Y, Hayashi K, Miki T, Mikami K, Mori M, Sakauchi F, Washio M, Ito Y, Suzuki K, Kubo T, Wakai K, Tamakoshi A. JACC Study Group: Association of serum phytoestrogen concentration and dietary habits in a sample set of the JACC Study. J Epidemiol 2005, 15(Suppl 2):S196-202. 10.2188/jea.15.S196, 16127234.
11. Hoikkala A, Mustonen E, Saastamoinen I, Jokela T, Taponen J, Saloniemi H, Wähälä K. High levels of equol in organic skimmed Finnish cow milk. Mol Nutr Food Res 2007, 51:782-786. 10.1002/mnfr.200600222, 17576638.
12. Lundh TJO, Pettersson HI, Martinsson KA. Comparative levels of free and conjugated plant estrogens in blood plasma of sheep and cattle fed ostrogenic silage. J Agric Food Chem 1990, 38:1530-1534.
13. Common RH, Ainsworth L. Identification of equol in the urine of the domestic fowl. Biochim Biophys Acta 1961, 53:403-404. 10.1016/0006-3002(61)90452-8, 13880769.
14. Kuhn G, Hennig U, Kalbe C, Rehfeldt C, Ren MQ, Moors S, Degen GH. Growth performance, carcass characteristics and bioavailability of isoflavones in pigs fed soy bean based diets. Arch Anim Nutr 2004, 58:265-276. 10.1080/00039420412331273295, 15570741.
15. Lund TD, Munson DJ, Adlercreutz H, Handa RJ, Lephart ED. Androgen receptor expression in the rat prostate is down-regulated by dietary phytoestrogens. Reprod Biol Endocrinol 2004, 2:5. 10.1186/1477-7827-2-5, 340387, 14728729.
16. Pike J, Holmes D, Kamalati T, Davies D, Tolhurst R, Mazhar D, Fishpool S, al-Jehani R, Waxman J, Zelent A, Lemoine NR, Ali S, Buluwela L. Silencing of androgen-regulated genes using a fusion of AR with the PLZF transcriptional repressor. Oncogene 2004, 23:7561-7570. 10.1038/sj.onc.1208030, 15334066.
17. Legg RL, Tolman JR, Lovinger CT, Lephart ED, Setchell KD, Christensen MJ. Diets high in selenium and isoflavones decrease androgen-regulated gene expression in healthy rat dorsolateral prostate. Reprod Biol Endocrinol 2008, 6:57. 10.1186/1477-7827-6-57, 2607280, 19025659.
18. Pendleton JM, Tan WW, Anai S, Chang M, Hou W, Shiverick KT, Rosser CJ. Phase II trial of isoflavone in prostate-specific antigen recurrent prostate cancer after previous local therapy. BMC Cancer 2008, 8:132. 10.1186/1471-2407-8-132, 2394534, 18471323.
19. Hedlund TE, Maroni PD, Ferucci PG, Dayton R, Barnes S, Jones K, Moore R, Ogden LG, Wähälä K, Sackett HM, Gray KJ. Long-term dietary habits affect soy isoflavone metabolism and accumulation in prostatic fluid in caucasian men. J Nutr 2005, 135:1400-1406.
20. Rannikko A, Petas A, Rannikko S, Adlercreutz H. Plasma and prostate phytoestrogen concentrations in prostate cancer patients after oral phytoestogen supplementation. Prostate 2006, 66:82-87. 10.1002/pros.20315, 16114063.
21. Gardner CD, Oelrich B, Liu JP, Feldman D, Franke AA, Brooks JD. Prostatic soy isoflavone concentrations exceed serum levels after dietary supplementation. Prostate 2009, 69:719-726. 10.1002/pros.20922, 2734961, 19180569.
22. Ellem SJ, Risbriger GP. The dual, opposing role of estrogens in the prostate. Ann NY Acad Sci 2009, 1155:174-186. Steroid Enzymes & Cancer, 10.1111/j.1749-6632.2009.04360.x, 19250203.
23. Lephart ED, Porter JP, Hedges DW, Lund TD, Setchell KD. Phytoestrogens: implications in neurovascular research. Curr Neurovasc Res 2004, 1:455-464. 10.2174/1567202043361974, 16181093.
24. Nomura M, Akama KT, Alves SE, Korach KS, Gustafsson JA, Pfaff DW, Ogawa S. Differential distribution of estrogen receptor (ER)-alpha and ER-beta in the midbrain raphe nuclei and periaqueductal gray in male mouse: Predominant role of ER-beta in midbrain serotonergic systems. Neuroscience 2005, 130:445-456. 10.1016/j.neuroscience.2004.09.028, 15664701.
25. Halbreich U, Kahn LS. Selective oestrogen receptor modulators-current and future brain and behavior applications. Expert Opin Pharmacother 2001, 1:1385-1398.
26. Thornton MJ, Taylor AH, Mulligan K, Al-Azzawi F, Lyon CC, O'Driscoll J, Messenger AG. The distribution of estrogen receptor beta is distinct to that of estrogen receptor alpha and the androgen receptor in human skin and the pilosebaceous unit. J Investig Dermatol Symp Proc 2003, 8:100-103. 10.1046/j.1523-1747.2003.12181.x, 12895004.
27. Ashcroft GS, Mills SJ, Lei K, Gibbons L, Jeong MJ, Taniguchi M, Burow M, Horan MA, Wahl SM, Nakayama T. Estrogen modulates cutaneous wound healing by downregulating macrophage migration inhibitory factor. J Clin Invest 2003, 111:1309-1318. 154440, 12727922.
28. Vij U, Kumar A. Phyto-oestrogens and prostatic growth. Natl Med J India 2004, 17:22-26.
29. Akaza H, Miyanaga N, Takashima N, Naito S, Hirao Y, Tsukamoto T, Fujioka T, Mori M, Kim WJ, Song JM, Pantuck AJ. Comparisons of percent equol producers between prostate cancer patients and controls: case-controlled studies of isoflavones in Japanese, Korean and American residents. Jpn J Clin Oncol 2004, 34:86-89. 10.1093/jjco/hyh015, 15067102.
30. Magee PJ, Raschke M, Steiner C, Duffin JG, Pool-Zobel BL, Jokela T, Wahala K, Rowland IR. Equol: a comparison of the effects of the racemic compound with that of the purified S-enantiomer on the growth, invasion, and DNA integrity of breast and prostate cells in vitro. Nutr Cancer 2006, 54:232-242. 10.1207/s15327914nc5402_10, 16898868.
31. Tanaka M, Fujimoto K, Chihara Y, Torimoto K, Yoneda T, Tanaka N, Hirayama A, Miyanaga N, Akaza H, Hirao Y. Isoflavone supplements stimulated the production of serum equol and decreased the serum dihydrotestosterone levels in healthy male volunteers. Prostate Cancer Prostatic Dis 2009, 12:247-252. 10.1038/pcan.2009.10, 2834330, 19597532.